CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic researchers to promote broader improvements to the healthcare system. She speaks with HBR's Editor-in-Chief Adi Ignatius about tackling challenges in an emerging industry.

Share Podcast

[HBR IdeaCast podcast series]

HBR IdeaCast
Episode 796

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

Listen | Podcast loading...

###

How a genetic testing company tackles the challenges of an emerging industry.

• Subscribe:

Apple Podcasts

Spotify

RSS

All episodes

Details

Transcript

May 20, 2021

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic researchers to promote broader improvements to the healthcare system. She speaks with HBR’s Editor-in-Chief Adi Ignatius about tackling challenges in an emerging industry.

• Subscribe On:

Apple

Spotify

RSS

Latest in this series

All episodes

This article is about HEALTH AND BEHAVIORAL SCIENCE

** Follow this topic

** Following

Related Topics:

• Technology and analytics

• Leadership

Original source